The effect of preoperative gemcitabine and nab-Paclitaxel compared to historical controls on RO surgical rate in patients with resectable pancreas cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Gemcitabine; Paclitaxel
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms GAP
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Status changed from recruiting to completed, according to abstract presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO 2015).
- 27 Jun 2012 Status changed from not yet recruiting to recruiting as reported by Australian New Zealand Clinical Trials Registry record.